Last update 21 Mar 2025

HPB-092

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms
HPB-092
Target
FLT3 x IRAK4
Action
inhibitors
Mechanism
FLT3 inhibitors(Tyrosine-protein kinase receptor FLT3 inhibitors), IRAK4 inhibitors(Interleukin-1 receptor-associated kinase 4 inhibitors)
Therapeutic Areas
NeoplasmsHemic and Lymphatic Diseases
Active Indication
Refractory acute myeloid leukemiaRelapsing acute myeloid leukemiaAcute Myeloid Leukemia+ [1]
Inactive Indication-
Originator Organization
Hangzhou Duoyu Biotechnology Co., LtdHangzhou Duoyu Biotechnology Co., Ltd
Active Organization
Hangzhou Duoyu Biotechnology Co., LtdHangzhou Duoyu Biotechnology Co., Ltd
Inactive Organization-
Drug Highest PhaseIND Approval
First Approval Date-
Regulation-
Login to view timeline

Related

100 Clinical Results associated with HPB-092
Login to view more data
100 Translational Medicine associated with HPB-092
Login to view more data
100 Patents (Medical) associated with HPB-092
Login to view more data
100 Deals associated with HPB-092
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Refractory acute myeloid leukemiaIND Approval
China
Hangzhou Duoyu Biotechnology Co., LtdHangzhou Duoyu Biotechnology Co., Ltd
12 Mar 2025
Relapsing acute myeloid leukemiaIND Approval
China
Hangzhou Duoyu Biotechnology Co., LtdHangzhou Duoyu Biotechnology Co., Ltd
12 Mar 2025
Acute Myeloid LeukemiaIND Approval
United States
Hangzhou Duoyu Biotechnology Co., LtdHangzhou Duoyu Biotechnology Co., Ltd
09 Oct 2024
Adult Acute Myeloblastic LeukemiaPreclinical
China
Hangzhou Duoyu Biotechnology Co., LtdHangzhou Duoyu Biotechnology Co., Ltd
18 Apr 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free